Medical review pending · noindex

Procedure comparison

UroLift vs Rezūm: Implant or Water-Vapor Therapy?

UroLift and Rezūm both aim to improve urinary flow without conventional tissue resection, but they work differently. UroLift mechanically retracts tissue with implants; Rezūm delivers water vapor so treated tissue changes over time. The decision turns on anatomy, tolerance for an implant versus tissue ablation, expected symptom trajectory, catheter planning, sexual priorities, retreatment evidence and local expertise.

Decision-support boundary: This draft does not diagnose obstruction, select a procedure, or tell anyone to stop medication. Inability to urinate, fever with urinary symptoms, heavy bleeding, severe pain or rapidly worsening symptoms need prompt medical attention.

Direct answer

The better option is the one that fits measured anatomy and the outcomes you prioritize after contraindications, clinician experience, evidence limits and the complete recovery pathway are reviewed. Neither side of this comparison is universally superior.

Start by confirming why symptoms are occurring. Lower urinary tract symptoms can reflect prostatic obstruction, bladder dysfunction, infection, urethral narrowing, medicines, neurologic conditions or more than one factor. NIDDK notes that tests help clinicians diagnose urinary problems and determine treatment options. A procedure comparison becomes useful only after that diagnostic work is connected to the actual choice.

UroLift (prostatic urethral lift) vs Rezūm (water-vapor thermal therapy): decision matrix

Decision factorUroLift (prostatic urethral lift)Rezūm (water-vapor thermal therapy)
MechanismPermanent implants hold obstructing prostatic tissue away from the urethra.Controlled water vapor is delivered into selected tissue, which is then resorbed over time.
Immediate pathwayNo tissue is intentionally removed or thermally destroyed.Ablated tissue changes over time, so improvement may not be immediate.
Anatomy fitEligibility depends on measured size, configuration, current labeling and clinician assessment.Treatment plan depends on gland size, obstructing zones and current labeling.
Catheter questionSome patients avoid a catheter; others need one based on swelling, retention risk or center protocol.A catheter is commonly discussed because post-treatment swelling can temporarily worsen emptying.
Sexual outcomesOften discussed when ejaculation is a priority, but no individual outcome is guaranteed.Also discussed as a sexual-function-conscious option; separate ejaculation from erection and fertility.
Future considerationsImplants remain in place and can matter for future procedures or imaging discussions.No implant remains, but prior ablation and symptom response still inform future care.

This table describes decision dimensions, not a personalized recommendation. Device labeling, guideline language, techniques and local pathways can change; verify current details with the treating clinicians.

When the first pathway may enter the discussion

  • You prefer a mechanical approach without heat or planned tissue destruction.
  • Your anatomy fits the device and your urologist has relevant implant experience.
  • You have discussed how implants could affect future procedures or imaging.

When the second pathway or another route may fit

  • You prefer an implant-free ablative approach and accept a delayed response.
  • Your anatomy fits the intended treatment zones.
  • You have a clear catheter and early symptom-flare plan.

Do not compare unlike outcomes

Ask whether a study reports symptom score, peak urinary flow, quality of life, catheter independence, adverse events or repeat treatment. Those outcomes are related but not interchangeable. Also check the starting severity, prostate anatomy, exclusions, follow-up duration and how many participants supplied data at the reported time point. A five-year result from a selected trial population is not a guarantee for an individual.

For sexual outcomes, separate erection, ejaculation, orgasm, libido and fertility. A statement that erectile function was stable does not establish that antegrade ejaculation was preserved. For recovery, separate time to discharge, catheter removal, return to work, urinary irritation and full activity. Marketing phrases that collapse these outcomes can make a procedure appear more certain than the evidence supports.

Questions to take to the consultation

  1. Does my prostate anatomy fit both procedures?
  2. How do you assess median-lobe or bladder-neck obstruction?
  3. What is your catheter protocol for each option?
  4. When should symptom improvement be evaluated?
  5. How do your own retreatment results compare with published evidence?
  6. How are ejaculation, erection and fertility documented?
  7. Would an implant affect future MRI or procedure planning?
  8. What would make you recommend neither option?
Useful request: Ask the clinician to mark which facts are known from your testing, which are estimates from published evidence, and which depend on the center’s own protocol. Request written catheter, medication and after-hours instructions before scheduling.

Evidence and review status

This page uses authoritative patient guidance, a professional guideline and procedure-specific clinical evidence where available. It deliberately avoids unsourced prices, universal recovery times and promises of preserved sexual function. It remains excluded from the XML sitemap until a qualified medical reviewer checks every material claim, current device labeling and the final comparison language.

Sources accessed September 21, 2026. A source link does not mean the source endorses UriSmooth or this page.

Frequently asked questions

1. What should I know about the main difference?

The main difference is one decision dimension, not a verdict for UroLift (prostatic urethral lift) or Rezūm (water-vapor thermal therapy). Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

2. What should I know about speed of improvement?

Speed of improvement is one decision dimension, not a verdict for UroLift (prostatic urethral lift) or Rezūm (water-vapor thermal therapy). Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

3. What should I know about implants?

Implants changes what remains after treatment and what information is available later. Ask whether UroLift (prostatic urethral lift) or Rezūm (water-vapor thermal therapy) leaves an implant, supplies tissue for examination, or alters future imaging and procedural choices.

4. What should I know about steam treatment?

Steam treatment is one decision dimension, not a verdict for UroLift (prostatic urethral lift) or Rezūm (water-vapor thermal therapy). Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

5. What should I know about catheter use?

Catheter use is part of the practical UroLift (prostatic urethral lift) versus Rezūm (water-vapor thermal therapy) decision. Ask whether a catheter is planned, what triggers removal, where a voiding trial occurs and who responds if emptying fails. Your baseline residual urine and bladder function can matter more than a generic average.

6. What should I know about median-lobe anatomy?

Median-lobe anatomy can change whether either side of this comparison is technically suitable. Have the clinician connect current imaging and test findings to UroLift (prostatic urethral lift), Rezūm (water-vapor thermal therapy) and any excluded option; do not infer eligibility from symptoms or an old size estimate alone.

7. What should I know about prostate size?

Prostate size can change whether either side of this comparison is technically suitable. Have the clinician connect current imaging and test findings to UroLift (prostatic urethral lift), Rezūm (water-vapor thermal therapy) and any excluded option; do not infer eligibility from symptoms or an old size estimate alone.

8. What should I know about ejaculation?

Ejaculation must be defined before comparing UroLift (prostatic urethral lift) with Rezūm (water-vapor thermal therapy). Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

9. What should I know about erections?

Erections must be defined before comparing UroLift (prostatic urethral lift) with Rezūm (water-vapor thermal therapy). Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

10. What should I know about retreatment?

Retreatment should be compared at the same follow-up interval with the same definition. For UroLift (prostatic urethral lift) and Rezūm (water-vapor thermal therapy), ask for the number treated, number assessed later, repeat-procedure criteria and the treating center’s own follow-up process.

11. What should I know about future procedures?

Future procedures changes what remains after treatment and what information is available later. Ask whether UroLift (prostatic urethral lift) or Rezūm (water-vapor thermal therapy) leaves an implant, supplies tissue for examination, or alters future imaging and procedural choices.

12. What should I know about choosing neither?

Choosing neither is one decision dimension, not a verdict for UroLift (prostatic urethral lift) or Rezūm (water-vapor thermal therapy). Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

Next decision

Return to the BPH procedure decision hub, compare medication versus a procedure, or build a recovery and catheter plan. UriSmooth is not presented as a substitute for evaluation or a procedure.